C Staiger
-
- Cardiovascular Function and Risk Factors 5
- Heart Failure Treatment and Management 5
- Cardiac pacing and defibrillation studies 3
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Blood Pressure and Hypertension Studies 2
- Family Practice top 5%
- Geriatrics and Gerontology top 5%
-
- Eicosanoids and Hypertension Pharmacology 2
-
- Pharmacogenetics and Drug Metabolism 2
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Michał TenderaEllen B. RoeckerPaul MohaçsiHenry KrumAndrew J.S. CoatsMilton PackerHugo A. KatusJean L. Rouleau
- Cited by
- Cardiology and Cardiovascular MedicineFamily PracticeEndocrinology, Diabetes and Metabolism
- Journals
- British Journal of Clinical Pharmacology (3 papers)New England Journal of Medicine (2 papers)Journal of the American College of Cardiology (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
C Staiger
19 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cardiology and Cardiovascular Medicine 4.3k
- Family Practice 83
- Endocrinology, Diabetes and Metabolism 552
- Complementary and alternative medicine 219
- Geriatrics and Gerontology 89
Countries citing papers authored by C Staiger
This map shows the geographic impact of C Staiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Staiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Staiger more than expected).
Fields of papers citing papers by C Staiger
This network shows the impact of papers produced by C Staiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Staiger. The network helps show where C Staiger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Staiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 2 | |
| 2 | 2008 | 156 | |
| 3 | Irbesartan in Patients with Heart Failure and Preserved Ejection Fractionbreakdown → | 2008 | 1362 |
| 4 | Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failurebreakdown → | 2002 | 928 |
| 5 | Effect of Carvedilol on Survival in Severe Chronic Heart Failurebreakdown → | 2001 | 2162 |
| 6 | 1990 | 8 | |
| 7 | 1989 | 1 | |
| 8 | 1986 | 13 | |
| 9 | [Effect of metronidazole on phenazone metabolism]. | 1984 | 5 |
| 10 | 1984 | 9 | |
| 11 | [Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]. | 1984 | 1 |
| 12 | Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. | 1984 | 18 |
| 13 | Effect of the thromboxane synthetase inhibitor Dazoxiben (UK 37-248) on the metabolism of antipyrine in patients with enhanced platelet aggregation. | 1984 | 1 |
| 14 | 1983 | 53 | |
| 15 | [Prescription figures and adverse effects of digitalis glycosides. A 2-year comparison of inpatients at a university hospital]. | 1983 | 2 |
| 16 | 1982 | 47 | |
| 17 | 1982 | 10 | |
| 18 | [Influence of ranitidine on antipyrine metabolism (author's transl)]. | 1980 | 6 |
| 19 | Biphasic initial phase of platelet aggregation inhibition after oral aspirin. | 1980 | 3 |
| 20 | [Nephrotoxicity of drugs, for example the aminoglycoside antibiotics and X-ray contrast media]. | 1980 | 1 |
About C Staiger
C Staiger is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry and Internal Medicine, having authored 20 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers), Cardiac pacing and defibrillation studies (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.3k citations), Family Practice (83 citations) and Endocrinology, Diabetes and Metabolism (552 citations). C Staiger has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Michał Tendera, Ellen B. Roecker, Paul Mohaçsi, Henry Krum, Andrew J.S. Coats, Milton Packer, Hugo A. Katus, Jean L. Rouleau, Michael B. Fowler and M. Schultz. Their work appears in journals such as British Journal of Clinical Pharmacology, New England Journal of Medicine, Journal of the American College of Cardiology, Clinical Pharmacology & Therapeutics and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.